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Lymphatic remodeling in inflammation has been found in
tracheal mycoplasma infection, human kidney transplant,
skin inflammation, peritonitis, and corneal inflammation.
Here we investigated lymphangiogenesis in fibrotic area in
unilateral ureteral obstruction, a model of progressive renal
fibrosis, and evaluated the roles of vascular endothelial
growth factor (VEGF)-C and -D in the obstructed kidney.
Compared to sham-operated mice, the number of LYVE-1-
positive lymphatic vessels, the proliferation of LYVE-1-
positive lymphatic endothelial cells, along with VEGF-C and -D
mRNA expression were all significantly increased following
ureteral obstruction. Depletion of macrophages with
clodronate decreased lymphangiogenesis in the obstructed
kidney. VEGF-C expression was higher in M2- than in
M1-polarized macrophages from bone marrow–derived
macrophages, and also increased in Raw 264.7 or renal
proximal tubule cells by stimulation with TGF-b1 or TNF-a.
VEGF-D reversed the inhibitory effect of TGF-b1 on
VEGF-C-induced migration, capillary-like tube formation,
and proliferation of human lymphatic endothelial cells.
Additionally, the blockade of VEGF-C and VEGF-D signaling
decreased obstruction-induced lymphangiogenesis. Thus,
VEGF-C and VEGF-D are associated with lymphangiogenesis
in the fibrotic kidney in a mouse model of ureteral
obstruction.
Kidney International (2012) 83, 50–62; doi:10.1038/ki.2012.312;
published online 29 August 2012
KEYWORDS: fibrosis; lymphangiogenesis; macrophages; renal tubule;
unilateral ureteral obstruction
A typical function of lymphatic vessels is the regulation of
fluid in interstitial space and transport of immune cell and
nutrients.1 The lymphatic system is involved in many
pathological conditions such as tumor metastasis, wound
healing, and lymphedema. Recently, the lymphangiogenesis
in acute inflammatory conditions has been demonstrated
in tracheal myocoplasma infection,2 skin inflammation,3
peritonitis,4,5 and corneal inflammation.6 Lymphangiogenesis
in acute airway inflammation may be associated with
relief of mucosal edema, and intraperitoneal lipopolysacchar-
ide administration induces lymphangiogenesis in the
diaphragm.2,5
Macrophages have an important role in inflammatory-
induced lymphangiogenesis. Macrophages are involved in
vascular endothelial growth factor (VEGF)-A–induced inflam-
matory neovascularization in cornea.7 Tracheal macrophages
after mycoplasma infection also express VEGF-C and
VEGF-D that increase lymphatics.2 Studies have demonstrated
that the expression of VEGF-C in lymphatic vessel endothelial
hyaluronan receptor (LYVE)-1–positive and CD11b-positive
macrophages has a critical role in acute skin inflammation
and lipopolysaccharide-induced peritoneal inflammatory
lymphangiogenesis.3,5 These observations have indicated
that lymphangiogenic factors from macrophages are actively
involved in lymphangiogenesis in acute inflammatory condi-
tions. However, the function of macrophages may be
different according to the classically activated M1 and
alternatively activated M2 macrophages. Until now, the role
of polarized macrophages during lymphangiogenesis remains
unknown.
There is also a growing body of evidence that lymphatic
vascular remodeling is increased in chronic fibrotic condi-
tions.3–5,8,9 Lymphatic endothelial proliferation has been
detected in tubulointerstitial fibrotic regions in rat
remnant kidney model,10 and lymphangiogenesis occurred
at the site of tubulointerstitial lesions and strongly correlated
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with areas of fibrosis in human kidney transplant.9 Recently,
El-Chemaly et al.8 have demonstrated that lymphangiogen-
esis in idiopathic pulmonary fibrosis, a chronic progressive
disease, is contributed by CD11b-positive macrophages
and hyaluronic acid. However, there are few data about the
lymphangiogenesis in unilateral ureteral obstruction (UUO)
mice, a type of progressive renal fibrosis model.
In this study, we investigated lymphangiogenesis in a
mouse model of UUO and evaluated the roles of macro-
phages and renal proximal tubules as a source of VEGF-C in
UUO
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Figure 1 | For caption please refer page 52.
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UUO-induced lymphangiogenesis. We also investigated the
roles of VEGF-D in obstructed kidney. The results showed
that the density of proliferating lymphatic endothelial cells
was increased after ureteral obstruction, and that macro-
phages and proximal renal tubules were sources of VEGF-C
in UUO-induced lymphangiogenesis. VEGF-D also contrib-
uted to lymphangiogenesis in UUO kidney.
RESULTS
The number of LYVE-1-positive lymphatic vessels is increased
in the obstructed kidney
In the whole kidney image obtained by recombination of
sagittal sections, LYVE-1-positive lymphatics were mostly
located around platelet endothelial cell adhesion molecule-1
(PECAM-1)–positive renal vessels in the medullary portion
from sham-operated kidney (Supplementary Figure S1a
online). After 1 or 2 weeks of UUO, ureteral obstructed
kidney showed an increase in LYVE-1-positive lymphatic
vascular endothelial cell density with contracted renal
parenchyma and dilated renal pelvis (Supplementary Figures
S1b and c). After 4 weeks of UUO, LYVE-1-positive lympha-
tics were further dilated in the medullary portion of the
kidney and detected abundantly in fibrotic renal parenchyma
in the cortex, with more thinning of renal parenchyma and
more dilated renal pelvis (Supplementary Figure S1d online).
PECAM-1 was expressed not only on the endothelium of
blood vessels but also on the endothelium of some lymphatic
vessels (Figure 1a and Supplementary Figure S1 online).
In sham-operated kidney, LYVE-1-positive lymphatics were
seen only in the surrounding renal arteries and arterioles
(Figure 1a). The number of LYVE-1-positive vessels in the
renal cortex was increased from 1 week after UUO compared
with sham-operated mice (Figure 1a and b).
Proliferation of LYVE-1-positive lymphatic vessels in UUO
kidney
To determine whether LYVE-1-positive lymphatic endothelial
cells are proliferating in UUO or sham-operated kidney, we
stained kidney sections with Ki-67, a marker of cell
proliferation, and LYVE-1. In the sham-operated kidney, most
LYVE-1-positive endothelial cells were rarely stained with
Ki-67 (Figure 1c and d). In the UUO kidney, the numbers of
LYVE-1- and Ki-67-positive cells per unit area were increased
in the renal cortex, showing approximately 3.1- and 4.5-fold
increase over the sham-operated kidney after 1 and 2 weeks of
UUO, respectively (Figure 1c and d).
VEGFR-3, podoplanin, and Prox-1 are coexpressed on
LYVE-1-positive endothelial cells
To evaluate whether LYVE-1-positive endothelial cells were
costained with other lymphatic markers, kidney sections
from UUO mice were immunostained with an antibody
against VEGF receptor-3 (VEGFR-3), podoplanin, Prox-1, or
LYVE-1. LYVE-1-positive lymphatic vascular endothelial cells
were also immunostained with VEGFR-3 after 1 week of
UUO. A lymphatic endothelial cell transcription factor,
Prox-1, was also detected in the nucleus of the LYVE-1-
and podoplanin-positive lymphatic endothelial cells
(Supplementary Figures S2a and b online).
LYVE-1-positive vascular lymphatics remodeling correlates
with the severity of interstitial fibrosis
The severity of renal interstitial fibrosis progressively increased
after UUO (Figure 2). To assess whether the change of vascular
density of LYVE-1-positive lymphatics is correlated with the
progression of renal fibrosis, the kidney sections from sham-
operated and UUOmice were stained with a LYVE-1 antibody,
and with hematoxylin and eosin and Masson’s trichrome
stains. In sham-operated kidney, the presence of fibrotic
lesions was rare, and LYVE-1-positive lymphatics were only
found around the renal arteries and arterioles (Figure 2a). In
UUO kidney, fibrotic lesions in the cortex were progressively
increased after UUO in Masson’s trichrome–stained kidney
sections. Vascular density of LYVE-1-positive lymphatics was
increased in a time-dependent manner (Figure 2a and b).
Vasculature of LYVE-1-positive lymphatics was significantly
increased in the cortical interstitial fibrotic area after UUO,
which was not found in sham-operated kidney (Figure 2a and b).
The increase in renal cortical fibrosis was positively correlated
with the increase in the LYVE-1-positive lymphatics in unit
area (r2¼ 0.772, Po0.01).
Gene expression correlates with lymphangiogenesis in UUO
kidney
To identify changes in lymphangiogenic growth factors,
we performed quantitative real-time reverse-transcription
Figure 1 |Confocal microscopic images in sham-operated and unilateral ureteral obstruction (UUO) mouse kidney 1, 2, 3, and
4 weeks (w) after obstruction. (a) Double immunostaining of lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) and platelet
endothelial cell adhesion molecule-1 (PECAM-1) was carried out using sham-operated (Sham) and ureteral obstructed kidneys 1w, 3w, and
4w after operation. UUO kidney demonstrated abundant and enlarged LYVE-1-positive lymphatic vessels 1w, 3w, and 4w after obstruction.
PECAM-1-positive vascular density was slightly increased in mice 2w after ureteral obstruction compared with sham-operated mice.
Thereafter, PECAM-1-positive vascular density was gradually decreased. Bar¼ 50 mm. (b) The number of LYVE-1-positive lymphatic vessels
per unit area in sham-operated and fibrotic kidney (n¼ 6 in each group). Bars represent mean±s.d. *Po0.05 versus sham; **Po0.01 versus
sham. (c) Immunofluorescence study of LYVE-1 and Ki-67 in kidney. Kidneys from mice that underwent sham or UUO operation were
collected 1w after operation. Tissues were fixed in 4% formaldehyde solution, and frozen sections were then stained with LYVE-1 and Ki-67
antibodies. Arrows indicate proliferating lymphatic endothelial cells. Bar¼ 20mm. (d) Quantification of the number of LYVE-1- and Ki-67-
positive cells in sham-operated or UUO kidney 1w and 2w after operation. Note that the number of cells that are coimmunoreactive for
LYVE-1 and Ki-67 in UUO kidney was increased significantly compared with that of the kidney after sham operation (n¼ 6 in each group).
Data are expressed as mean±s.d. **Po0.01 versus sham in each time.
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PCR (qRT-PCR).7,11–16 As shown in Figure 3, the mRNA
expression of angiopoietin (Ang)1, VEGF-C, and VEGF-D
was increased 6-, 13-, and 6-fold 1 week after UUO,
respectively, compared with sham-operated kidney. The
increased mRNA level of VEGF-C and VEGF-D was
sustained up to 4 weeks, whereas the increased mRNA level
of Ang1 was decreased after 3 weeks of UUO. The mRNA
expression of VEGF-A was decreased 3 and 4 weeks
after UUO (Figure 3a). To evaluate changes in VEGF-C
mRNA level in glomeruli and renal tubules, we isolated
glomeruli from the kidney 1 week after UUO and
performed qRT-PCR. Our qRT-PCR data demonstrated
that the level of VEGF-C mRNA in renal tubules was
significantly increased after UUO operation compared
with the level of sham operation (Figure 3b). However, the
VEGF-C mRNA level in glomeruli was not significantly
changed compared with the level in sham-operated mice
(Figure 3b).
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Figure 2 | Immunohistochemical study of lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1), hematoxylin and eosin
(H&E), and Masson’s trichrome (MTS) stain on normal and fibrotic kidney sections after ureteral obstruction. (a) Kidneys from mice
that underwent sham operation or ureteral obstruction were collected 1 and 2 weeks (w) after operation. Bar¼ 50mm. (b) Correlation
between the number of LYVE-1-positive lymphatic vessels and renal cortical interstitial fibrosis defined as percentage of MTS-positive
fibrotic area (n¼ 6 in each group). Note that there is a positive correlation between the number of LYVE-1-positive lymphatic vessels and
fibrotic area in fibrotic kidney after ureteral obstruction. UUO, unilateral ureteral obstruction.
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Macrophage depletion decreases UUO-induced
lymphangiogenesis and renal injury
VEGF-C expression has been shown to increase in macro-
phages in acute inflammation.3–5 We therefore evaluated the
role of macrophages in lymphangiogenesis in UUO kidney by
depletion of the cells with liposomal clodronate. Adminis-
tration of liposomal clodronate reduced the number of F4/
80-positive macrophages in the kidney by approximately 92%
and markedly inhibited UUO-induced lymphangiogenesis
by approximately 85% (Figure 4a–c). Histological analysis
showed that depletion of macrophages reduced renal
interstitial fibrosis in UUO kidney (Figure 4d).
Knockdown of VEGF-C in macrophages decreases the
UUO-induced lymphangiogenesis
We evaluated the effect of adoptive VEGF-C knockdown
macrophage transfer on renal lymphangiogenesis after
UUO using VEGF-C-specific short hairpin RNA lentiviral
vector (VEGF-C shRNA). VEGF-C shRNA– or non-target
shRNA–transfected bone marrow–derived macrophages
were transferred into severe combined immunodeficiency
mice, and the lymphangiogenesis in the UUO kidney
was evaluated. Immunofluorescence study demonstrated
that VEGF-C shRNA–transfected macrophages significantly
decreased the UUO-induced increase of LYVE-1-positive
lymphatic vessels (Supplementary Figure S3 online).
Expression of VEGF-C dominantly increased in alternatively
activated M2 macrophages
Although the number of macrophages significantly increases
within UUO kidney and has an important role in UUO-
induced lymphangiogenesis in our experiment, macrophages
are heterogeneous in function and include classically
activated M1 and alternatively activated M2 macrophages.
It has been suggested that M2-polarized macrophages
promote angiogenesis and lymphangiogenesis in tumor.17–19
These findings led us to assess the expression and localization
of VEGF-C in alternatively activated M2 macrophages from
UUO kidney and primary-cultured bone marrow–derived
macrophages. To evaluate the VEGF-C expression in M2
or M1 macrophages in UUO kidney, we immunostained
the UUO kidney sections using an antibody against an
M2-polarized macrophage marker, mannose receptor
(CD206), or an M1-polarized macrophage marker, inducible
nitric oxide synthase (iNOS). Immunofluorescent findings
showed that about 33±4% of CD206-positive cells were
costained with VEGF-C in kidney sections after 1 week of
UUO (Figure 5a). iNOS-positive macrophages also expressed
VEGF-C (Figure 5b). We also examined the changes of
VEGF-C expression in M1- or M2-polarized macrophages
in vitro. Bone marrow–derived macrophages were stimu-
lated with interferon-g or interleukin (IL)-4 for 48 h to
induce the M1 or M2 macrophage phenotype and immuno-
blotting was performed with iNOS and an M2-polarized
macrophage marker, arginase-1. Treatment of macro-
phages with interferon-g increased the expression of
iNOS, and treatment with IL-4 increased the expression of
arginase-1 (Figure 5c and d). The expression of VEGF-C
protein in M2-polarized macrophages was higher than
in M1-polarized bone marrow–derived macrophages
(Figure 5e).
TGF-b1 or TNF-a increases VEGF-C expression in Raw 264.7
cells
We found that the transforming growth factor (TGF)-b1
level in UUO kidney was significantly higher than that in
sham-operated kidney in this experiment (Supplementary
Figure S4 online). As TGF-b1 and tumor necrosis factor
(TNF)-a have a major role in renal fibrosis, we evaluate
whether stimulation of macrophages with TGF-b1 or TNF-a
increases the expression of VEGF-C protein in Raw 264.7
cells, an established macrophage cell line.5,20–22 Treatment
with TGF-b1 at concentrations of 10 and 20 ng/ml increased
the expression of VEGF-C by approximately 2.6- and
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Figure 3 | Lymphangiogenic gene expression analysis by quantitative real-time reverse transcription PCR. (a) Fold changes of
gene expression are relative to sham at 1, 2, 3, and 4 weeks (w) after operation. The expression of mouse angiopoietin-1 (mAng1), mouse
vascular endothelial growth factor (mVEGF)-C, and VEGF-D in unilateral ureteral obstruction (UUO) kidney was significantly increased
compared with sham-operated mice (n¼ 3 in each group). (b) Relative expression of VEGF-C mRNA in renal tubules and glomeruli 1w after
UUO (n¼ 3 in each group). Bars represent mean±s.d. *Po0.05 versus sham; **Po0.01 versus sham; ##Po0.01 versus tubules in sham.
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2.1-fold, respectively (Supplementary Figure S5a online).
Treatment of Raw 264.7 cells with TGF type 1 receptor
inhibitors (LY364947 and SD208) and an inhibitor of TGF-b
superfamily type I activin receptor–like kinase (ALK)
receptors ALK4, 5, and 7 (SB431542) significantly decreased
TGF-b1-induced VEGF-C production (Supplementary
Figure S5b online). We also investigated the effects
of TNF-a on VEGF-C production in Raw 264.7 cells.
TNF-a at a concentration of 10 ng/ml increased VEGF-C
expression by approximately 3.1-fold compared with
control buffer–treated Raw 264.7 cells (Supplementary
Figure S5c). These results indicate that TGF-b1 or TNF-a
increases VEGF-C production and that TGF type 1 receptor
and TGF-b superfamily type I ALK receptors 4, 5, and 7 are
involved in TGF-b1-mediated VEGF-C expression.
TGF-b1 or TNF-a increases VEGF-C expression in proximal
tubular cells
As VEGF-C from activated macrophages is involved in
lymphangiogenesis in ureteral obstructed kidneys, we
explored other sources of VEGF-C in the UUO kidney.
Thus, we immunostained kidney sections with anti-VEGF-C
and aquaporin 1 antibodies. Immunofluorescence findings
showed that VEGF-C expression in UUO kidney was
increased in renal tubules compared with sham-operated
kidney, and VEGF-C-positive renal tubule cells were
costained with aquaporin 1, a marker of proximal tubule in
UUO kidney (Figure 6a). Aquaporin 1 was expressed on the
apical and basolateral membrane of the proximal tubule in
sham-operated and UUO kidney as previously reported.23,24
To evaluate changes of VEGF-C protein expression in mouse
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Figure 4 | Effect of macrophage depletion and blockade of vascular endothelial growth factor (VEGF)-C on unilateral ureteral
obstruction (UUO)–induced lymphangiogenesis in the kidney. For systemic depletion of macrophages, clodronate liposome (CDL,
50mg/kg) was administered through the peritoneum 1 day before operation and every second day before collecting kidney sample. Empty
control liposome (CL) was injected as a control. Kidneys from mice that underwent sham or UUO operation were collected 1 week after
operation. (a) Tissues were fixed in 4% formaldehyde solution, and kidney sections were then stained with F4/80 and lymphatic vessel
endothelial hyaluronan receptor-1 (LYVE-1) antibody. Note that administration of CDL markedly reduced the number of F4/80-positive
macrophages in the kidney and also suppressed lymphangiogenesis induced by ureteral obstruction. (b) The number of F4/80-positive
macrophages in unit area of the kidney. The number of F4/80-positive macrophages in sham-operated or UUO kidney was measured
in each given area (3.64mm2, n¼ 4 in each group). Bars represent mean±s.d. (c) Area density of LYVE-1-positive lymphatic endothelial
cells in sham-operated and fibrotic kidney (n¼ 4 in each group). Bar graph shows the area density of the positively stained area to the total
field. (d) Fibrosis of the sham-operated and UUO kidneys (n¼ 4 in each group). Bars represent mean±s.d. **Po0.01 versus shamþCL;
#Po0.05 versus UUOþCL; ##Po0.01 versus UUOþCL.
Kidney International (2012) 83, 50–62 55
AS Lee et al.: Lymphangiogenesis in UUO model bas i c re sea rch
proximal tubular (MPT) and HK2 cells, established mouse
and human proximal tubular cell lines, respectively, we
stimulated MPT and HK2 cells with TGF-b1 or TNF-a for
24 h and performed immunoblot analysis. Treatment with
TGF-b1 (10 ng/ml) or TNF-a (10 ng/ml) increased VEGF-C
expression by approximately 2.6- or 2.9-fold, respectively,
compared with control buffer–treated MPT cells (Figure 6b
and c). Treatment with TGF-b1 (10 ng/ml) or TNF-a (10 ng/
ml) increased VEGF-C expression by about 3.5- or 3.7-fold,
respectively, compared with control buffer–treated HK2 cells
(Figure 6d and e). We also found that LY364947, SD208, and
SB431542 significantly decreased TGF-b1-induced VEGF-C
production in MPT cells (Figure 6f). These data suggest that
TGF-b1 increases VEGF-C production through the TGF
type 1 receptor and TGF-b type I receptors ALK4-, 5-, and
7-dependent signal pathway in MPT cells.
VEGF-D reverses the inhibitory effect of TGF-b1 on
VEGF-C-induced in vitro lymphangiogenesis
TGF-b1 is a negative regulator in lymphangiogenesis and
inhibits lymphatic regeneration during wound repair.25–27
Tube formation, migration, and proliferation of lymphatic
endothelial cells are important components in in vitro
lymphangiogenesis. We evaluated the effect of TGF-b1 on
VEGF-C-induced in vitro lymphangiogenesis using human
lymphatic endothelial cells (hLECs). In line with previous
data, treatment of hLECs with TGF-b1 significantly decreased
VEGF-C-induced tube formation, migration, and prolifera-
tion (Figure 7a–d).26 We also found that mRNA and protein
expression of VEGF-C and VEGF-D increased in UUO
kidney compared with sham-operated mice (Figures 3a, 7e
and f). We further evaluated whether treatment with
VEGF-D ameliorates the inhibitory effect of TGF-b1 on
VEGF-C-induced capillary-like tube formation, migration,
and proliferation of hLECs. VEGF-D significantly reversed
the suppressive effect of TGF-b1 on VEGF-C-induced
capillary-like tube formation, migration, and proliferation
of hLECs (Figure 7a–d).
Blockade of VEGF-C and VEGF-D decreases UUO-induced
lymphangiogenesis
The ligands of VEGFR-3 are known as VEGF-C and
VEGF-D.12,28 To ascertain the role of VEGF-C and VEGF-D
in UUO-induced lymphangiogenesis, we blocked the effect of
VEGF-C and VEGF-D using adenovirus encoding the soluble
extracellular domain of VEGFR-3 (Ad-sVEGFR3).29 Treat-
ment of UUO-operated mice with Ad-sVEGFR3 decreased
the UUO-induced increase of the number of lymphatic
vessels in the renal cortex compared with mice treated with
adenovirus-encoding b-galactosidase (Ad-b-galactosidase;
Figure 7g). The sham-operated mice treated with the
Ad-sVEGFR3 showed no signicant differences from the
sham-operated mice treated with Ad-b-galactosidase.
Lymphatic remodeling in fibrotic human kidney after ureteral
obstruction
To evaluate whether there is lymphatic vascular remodeling in
fibrotic human kidney after ureteral obstruction due to
ureteral cancer, the kidney sections were immunostained with
anti-D2-40 (human lymphatic vascular marker) antibody.
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Figure 5 | Immunofluorescence of mannose receptor (CD206), inducible nitric oxide synthase (iNOS), and vascular endothelial
growth factor (VEGF)-C in kidney and immunoblot analyses of VEGF-C in bone marrow–derived macrophages. (a, b) Unilateral
ureteral obstruction (UUO) kidneys were harvested 1 week (w) after operation. Tissues were fixed in 4% formaldehyde solution, and
frozen sections were then stained with anti-F4/80, anti-iNOS, anti-CD206, and anti-VEGF-C antibodies. Nuclei were stained with DAPI
(4’,6-diamidino-2-phenylindole; blue color). Note that VEGF-C was costained with F4/80- and CD206-positive cells, and also with F4/80- and
iNOS-positive cells in UUO kidney. Bar¼ 20 mm. (c–e) The bone marrow–derived macrophages were collected and treated with interferon
(IFN)-g or interleukin (IL)-4 for 48 h. Blots (top) were probed with an anti-VEGF-C, anti-iNOS, or anti-arginase (Arg)-1 antibody. iNOS was used
as a marker of M1 macrophage and Arg-1 as a marker of M2 macrophage. The membrane was stripped and reprobed with an anti-actin
antibody to control for protein loading in each lane. Note that the expression of VEGF-C in bone marrow–derived M2 macrophages after
stimulation with IL-4 was significantly higher than that of M1 macrophages after stimulation with IFN-g (n¼ 4). Bars represent mean±s.d.
**Po0.01 versus control buffer (CB).
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In normal human kidney tissues, D2-40 positive–stained endo-
thelium of lymphatic vascular system was located just around
renal arterioles and arteries (Supplementary Figure S6 online).
However, the density of D2-40-positive lymphatics in inter-
stitial fibrotic area in ureteral obstructed human kidney was
increased compared with normal kidney.
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necrosis factor (TNF)-a at indicated concentrations for 24 h. Blots (top) were probed with an anti-VEGF-C antibody and the membrane was
reprobed with an anti-actin antibody to control for protein loading in each lane. Note that the expression of VEGF-C in MPT cells after
stimulation with TGF-b1 or TNF-a was significantly increased compared with that after stimulation with control buffer (CB; n¼ 3). (d, e) HK2
cells were treated with TGF-b1 or TNF-a at indicated concentrations for 24 h. Blots were probed with an anti-VEGF-C antibody and reprobed
with an anti-actin antibody to control for protein loading in each lane. Note that the expression of VEGF-C in HK2 cells after stimulation with
TGF-b1 or TNF-a was significantly increased compared with that after stimulation with CB (n¼ 3). (f) MPT cells were treated with TGF-b1
(10 ng/ml), LY364947 (LY), SD208 (SD), and SB431542 (SB) for 24 h. Blots (top) were probed with an anti-VEGF-C antibody, and the
membrane was reprobed with an anti-actin antibody to control for protein loading in each lane (n¼ 3). Bars represent mean±s.d.
*Po0.05 versus CB; #Po0.05 versus CBþ TGF-b1.
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Figure 7 |Vascular endothelial growth factor (VEGF)-D reverses the inhibitory effect of transforming growth factor (TGF)-b1 on
VEGF-C-induced lymphangiogenesis. (a) Phase-contrast photographs of capillary-like tube formation in extracellular matrix (ECM) gel.
Gels were incubated for 16 h in the presence of the indicated reagents (VEGF-C 100 ng/ml, TGF-b1 10 ng/ml, and VEGF-D 50 or 100 ng/ml).
Capillary-like tube formation was assayed in three-dimensional matrices of ECM gel as described in ‘Materials and Methods’. Bar at lower
right¼ 50 mm. (b) Quantification of capillary-like tube formation. Tube formation was quantified by the number of tubes using phase-
contrast microscopy. Bars represent means±s.d. from four independent experiments. (c) Migration assay, control buffer (CB), VEGF-C
(100 ng/ml), TGF-b1 (10 ng/ml), and/or VEGF-D (50 or 100 ng/ml) in endothelial basal medium-2 containing 1% bovine serum albumin were
placed in the bottom wells of the chamber. Cells that migrated through to the lower chamber were stained with Diff-Quik solution and
counted at  200 magnification as described in ‘Materials and Methods’. Bars represent means±s.d. from four independent experiments.
(d) Human lymphatic endothelial cells (hLECs) were incubated with CB, VEGF-C (100 ng/ml), TGF-b1 (10 ng/ml), and VEGF-D (50 or
100 ng/ml). After the 48-h incubation period, hLEC proliferation was measured with an XTT assay. Bars represent means±s.d. from four
independent experiments. (e, f) The relative ratio of VEGF-C (e) and VEGF-D (f) was measured by enzyme-linked immunosorbent assay
(ELISA). The level of VEGF-C and VEGF-D was quantified by ELISA in sham-operated or unilateral ureteral obstruction (UUO) kidneys at 1, 2, 3,
and 4 weeks (w) after surgery. Results were similar in three independent experiments. (g) The number of LYVE-1-positive lymphatic vessels
after treatment with intravenous injection of 109 p.f.u. adenovirus encoding the soluble extracellular domain of VEGFR-3 (Ad-sVEGFR3) or
control adenovirus encoding b-galactosidase (Ad-b-galactosidase) before and 7 days after ureteral obstruction. Note that the administration
of Ad-sVEGFR3 suppressed lymphangiogenesis induced by UUO. Bars represent mean±s.d. (h) Schematic summary of lymphangiogenesis
in the UUO model. *Po0.05 versus CB; **Po0.01 versus CB or shamþAd-b-galactosidase; ***Po0.001 versus CB; wPo0.05 versus VEGF-C
alone; zPo0.01 versus VEGF-C alone; ##Po0.01 versus VEGF-Cþ TGF-b1.
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DISCUSSION
The present study has revealed that interstitial fibrosis in
mouse ureteral obstructed kidney and human fibrotic kidney
is accompanied by lymphangiogenesis, and that the degree
of lymphangiogenesis is correlated with the severity of renal
fibrosis. Identification of lymphangiogenic factors showed that
mRNA level of VEGF-C and VEGF-D was specifically
increased in the UUO kidney in a time-dependent manner.
Our results also revealed that sources of VEGF-C were
macrophages and renal tubule cells (Supplementary Figure
S5 online). Supporting the observations, depletion of macro-
phages decreased the UUO-induced lymphangiogenesis in
fibrotic kidney, and treatment of MPT and HK2 cells with
TGF-b1 or TNF-a increased VEGF-C expression. VEGF-D
reverses the inhibitory effect of TGF-b1 on VEGF-C-induced
in vitro lymphangiogenesis.
VEGF-C production from activated macrophages is
associated with lymphangiogenesis in inflammatory condi-
tions.3–5,30 In line with previous results,21,31,32 our histologi-
cal data showed that infiltration of F4/80-positive
macrophages was increased in UUO kidney, and this
increased infiltration of macrophages was associated with
an increase in lymphatic endothelial cell density. Supporting
the observation, treatment with liposomal clodronate to
deplete macrophages decreased UUO-induced lymphangio-
genesis. These observations suggest that macrophages have a
critical role in UUO-induced lymphangiogenesis.
One of the important issues in lymphangiogenesis in renal
fibrosis is the source of lymphangiogenic factors in the kidney.
A recent study has indicated that VEGF-C and VEGF-D are
involved in lymphangiogenesis in various inflammatory
conditions.2,3 Lymphatic vasculature remodeling has been
demonstrated in tracheal mycoplasma infection, and VEGF-C
or VEGF-D expression is increased in macrophages in mucosal
inflammation.2 It has been reported that lipopolysaccharide-
induced acute peritoneal inflammation increases peritoneal
lymphangiogenesis, and that VEGF-C and VEGF-D from
LYVE-1-positive macrophages are involved in acute inflam-
matory lymphangiogenesis.3,5 Supporting these findings, our
qRT-PCR analysis data revealed that UUO predominantly
increased the level of VEGF-C and VEGF-D mRNA in the
kidney. Taken together, activated macrophages are involved in
lymphangiogenesis in acute inflammation by the production
and release of lymphangiogenic growth factors, and VEGF-C
and VEGF-D may be a major lymphangiogenic factor in
UUO-induced lymphangiogenesis.
M1-polarized macrophages are activated by T-helper 1
cytokines such as interferon-g, IL-1, and lipopolysaccharide,
and M2-polarized macrophages are activated by T-helper 2
cytokines such as IL-4 and IL-13. Animal experiments have
demonstrated that there are different forms of polarization
of macrophages in chronic inflammatory state, such as
chemical- and pathogen-induced chronic lung inflamma-
tion33 and adipose tissue inflammation in high-fat diet–
induced obese mice.34 Recently, it has been reported that M1
or M2 activation signals may determine the influence of
VEGF production from macrophages.17 These findings
suggest that macrophage polarization may have a role in
UUO-induced lymphangiogenesis. However, the effect of
polarized macrophages during lymphangiogenesis has not
been well defined. Our data showed that the expression of
VEGF-C protein was higher in IL-4-induced M2-polarized
macrophages than in interferon-g-induced M1-polarized
macrophages of bone marrow–derived cells, and the expres-
sion of VEGF-C protein in Raw 264.7 cells was also higher
after M2 polarization than after M1 polarization. In addition,
VEGF-C protein was expressed on M2-polarized macro-
phages in UUO kidney. These results indicate that alter-
natively activated macrophages may be involved in
UUO-induced lymphangiogenesis.
We also evaluated whether VEGF-C expression increased
in renal tubules after ureteral obstruction. It has been
reported that lymphangiogenesis is associated with VEGF-C
expression in inflammatory mononuclear cells and renal
proximal tubular epithelial cells in human renal biopsy
specimen.32 Our immunofluorescence data showed that
VEGF-C expression was significantly increased in renal proxi-
mal tubule cells after UUO compared with the VEGF-C
expression after sham operation. To support these findings,
we treated the MPT and HK2 cells with TGF-b1 or TNF-a,
which have been shown to increase in the UUO mouse
model.20 We found that VEGF-C expression was significantly
increased in MPT cells after stimulation with TGF-b1 or
TNF-a compared with the control. Our data also demon-
strated that treatment with TGF-b1 or TNF-a increased the
expression of VEGF-C in HK2 cells. Taken together, TGF-b1-
and TNF-a-induced VEGF-C expression in renal proximal
tubules may exhibit a paracrine effect on lymphangiogenesis
in renal fibrosis. However, TGF-b1 is also known to decrease
lymphangiogenesis, and inhibition of TGF-b1 increases
lymphatic regeneration.26,27 We found that the expression
of VEGF-C and VEGF-D lymphangiogenic factors was
increased during UUO-induced renal fibrosis. Recently, it
has been suggested that a coordinated expression of
lymphangiogenic and anti-lymphangiogenic cytokine is
linked to lymphatic function.35 Therefore, the expression of
both negative and positive lymphangiogenic regulators may
have a role in UUO-induced lymphangiogenesis. Supporting
the contention, our results showed that VEGF-D abolished
TGF-b1-induced negative lymphangiogenenic effect and was
also actively involved in UUO-induced lymphangiogenesis
(Figure 7).
Although tubular atrophy is a consequence of epithelial
cell apoptosis and epithelial to mesenchymal transdifferentia-
tion, it is usually linked to interstitial fibrosis. Fibrosis
presents a number of characteristic features including a
chronic inflammatory reaction and an increased interstitial
fibroblast and matrix accumulation.36 The interstitial cellular
response to UUO is associated with an increase of inflam-
matory reaction.21 It is well known that lymphangiogenesis is
associated with acute or chronic inflammation. Therefore,
tubular atrophy in UUO can be linked to lymphangiogenesis
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in the interstitial fibrotic area. As expressions of angiogenic
or lymphangiogenic growth factors may increase during
tubular atrophy and renal fibrosis after ureteral obstruction,
there may be less injury of the lymphatic endothelial cells
compared with renal tubule cells. During renal fibrosis with
tubular atrophy, the fibrotic kidney decreases in size.
Therefore, the density of lymphatic vessels in fibrotic kidney
may be higher than that of renal tubular cells. The relative
increase of lymphatic endothelial cells per unit area in severe
renal fibrotic kidney after UUO can be one of the
explanations for a mechanism in UUO-induced lymphan-
giogenesis.
We found that injured renal tubules in fibrotic area did not
expressed VEGF-C, whereas uninjured renal tubules adjacent
to the fibrotic area expressed VEGF-C. Our immunoblot data
demonstrated that treatment with TGF-b1 or TNF-a
increased VEGF-C expression in renal tubules. Therefore, it
can be suggested that TGF-b1- or TNF-a-induced VEGF-C
expression from intact renal tubules may have a paracrine
effect on lymphangiogenesis in the renal fibrotic area.
Another important issue in lymphangiogenesis in renal
fibrosis is whether lymphangiogenesis in fibrotic kidney is
associated with a beneficial role in the destructing process of
renal parenchyma after ureteral obstruction. Recently,
disturbance of lymph circulation by lymphatic ligation has
been shown to induce renal brosis; such changes in lymphatic
flow can be a factor for renal fibrosis.37 A study has
demonstrated that fibrosis in soft tissue involves impairment
in lymphatic cell proliferation and lymphatic function, and
suggested that the fibrotic process decreases lymphatic repair
and regeneration of normal capillary lymphatics.38 However,
Kerjaschki et al.9 have demonstrated that lymphangiogenesis
contributes to the export of the inflammatory cell infiltrate in
human transplants.9 In the present study, our data showed
that depletion of macrophages by clodronate treatment
decreased lymphatic endothelial cell density and renal tubular
injury score in UUO kidney, indicating that macrophages
have important roles in lymphangiogenesis and in the
destructing process in renal fibrosis. However, there is a
paucity of data on the functional role of renal lymphangio-
genesis in renal fibrotic process, and thus further studies are
needed.
In summary, our results have suggested that VEGF-C and
VEGF-D have a role in lymphangiogenesis in fibrotic kidney
of mice induced by UUO.
MATERIALS AND METHODS
Animal experiments: UUO model
Animal studies were reviewed and approved by the Institutional
Animal Care and Use Committee of Chonbuk National University.
Male C57BL/6 mice (Orient Bio, Seoul, Korea; 18–20 g body weight)
were used for the UUO model with the previously described method.21
Briefly, an incision was made in the midline of the abdomen, and the
left proximal ureter was exposed and was ligated at two separate
locations using 3-0 silk. Kidney samples were collected 1, 2, 3, and
4 weeks after ureteral obstruction. To block VEGF-C and VEGF-D
signaling, mice were treated with intravenous injection of 109 p.f.u.
Ad-sVEGFR3 before and 10 days after UUO.3 Ad-b-galactosidase
(109 p.f.u.) was used as a control. Ad-sVEGFR-3 and Ad-b-galactosi-
dase were provided by Dr Gou Young Koh (Korea Advanced Institute
of Science and Technology, DaeJeon, Republic of Korea).
Cells and reagents
For bone marrow–derived macrophages, bone marrow was isolated
from femurs and tibias of male C57BL/6 mice and cultured in
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum and 30% L929 conditioned media. MPT cells were
generously provided by Dr Lloyd G. Cantley (Yale University School
of Medicine, New Haven, CT). Raw 264.7 and HK2 cells (ATCC,
Manassas, VA) were cultured in Dulbecco’s modified Eagle’s
medium. hLECs were obtained from Lonza (Basel, Switzerland).
TGF-b1 was purchased from Sigma-Aldrich (St Louis, MO) and
TNF-a from R&D Systems (Minneapolis, MN). Recombinant
human VEGF-C and VEGF-D were purchased from R&D Systems.
Isolation of glomeruli and tubules for RNA extraction
Glomeruli were isolated using a modified method that was
previously described.39 One week after ureteral obstruction, male
C57BL/6 mice (Orient Bio; 18–20 g body weight) were anesthetized
with an intramuscular injection of ketamine (100mg/kg) and
xylazine (10mg/kg). Kidneys were removed, chopped into 1mm3
pieces, and digested in collagenase (1mg/ml collagenase A, 100U/ml
deoxyribonuclease I) at 37 1C for 30min with gentle agitation. The
cell suspension was then gently minced using a 100-mm mechanical
sieve, which was then washed with 5ml of phosphate-buffered
saline (PBS). The filtered cells were suspended in 3ml of PBS.
The glomeruli were isolated with a micropipette under a light
microscope. The isolated glomeruli and remaining cells were used
as glomeruli and renal tubules for mRNA extraction, respectively.
Immunofluorescence
Immunofluorescence staining was performed as described pre-
viously.40 For immunofluorescence studies, mouse kidneys fixed
with 4% paraformaldehyde were cryoprotected in 10% sucrose in
PBS (3 h at 4 1C), immersed in 20% sucrose/10% glycerol in PBS
(overnight at 4 1C), and then frozen in OCT Tissue-Tek compound
(VWR Scientific, Arlington Heights, IL) before preparing 10-mm-
thick cryosections. Anti-PECAM-1 (Chemicon International,
Temecula, CA), anti-VEGFR-3 (R&D Systems), anti-podoplanin
(Santa Cruz Biotechnology, Santa Cruz, CA), anti-Prox-1 (Reliatech,
Braunschweig, Germany), anti-Ki-67 (Thermo Fisher Scientific,
Fremont, CA), anti-mouse F4/80 (eBioscience, SanDiego, CA),
anti-aquaporin 1 (Santa Cruz Biotechnology), anti-iNOS (BD
Transduction Laboratories, San Jose, CA), and anti-VEGF-C
antibodies (Invitrogen, Carlsbad, CA) were used for mouse
kidney frozen sections. Secondary Alexa Fluor 488– or Alexa Fluor
555–conjugated antibodies to rat, rabbit, or hamster immunoglo-
bulins (1:1000; Invitrogen) were used to visualize antigen–antibody
complexes. Nuclei were stained with DAPI (4’,6-diamidino-
2-phenylindole). Digital images were obtained with a Zeiss Z1
microscope and a Zeiss LSM 510 confocal microscope (Carl Zeiss,
Go¨ttingen, Germany).
Histology and morphometric analysis of lymphatic vessels
Human and mouse kidneys were fixed in 10% neutral buffered
formalin and embedded in paraffin. Kidney sections were histologically
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evaluated with hematoxylin and eosin stain. The presence of interstitial
fibrosis in human and mouse kidney section was assessed with
Masson’s trichrome stain using a method that we used earlier.22 The
positive area of Masson’s trichrome stain was evaluated from the unit
area and expressed as a percentage per unit area using a digital image
analysis program (AnalySIS, Soft Imaging System, Mu¨nster, Germany).
For each kidney section, five randomly selected nonoverlapping fields
were analyzed. The number of lymphatic vessels per unit area was
measured with a modification of methods previously described.41 In
brief, five individual fields per kidney section were examined at  200
magnication, and the number of vessels per unit area
(0.45mm 0.45mm) was determined.
Immunohistochemistry
For immunohistochemistry, kidneys were fixed overnight in 4%
paraformaldehyde and embedded in paraffin. Four-micrometer
sections were cut, dewaxed, and dehydrated. Endogenous peroxidase
activity was blocked with 0.3% hydrogen peroxide in methanol for
30min. Next, antigen retrieval was performed with a mixture of
2mol/l HCl and 0.2% Triton X-100 in Tris-buffered saline for 30min
at room temperature. Slides were blocked with 10% normal goat
serum and 1% bovine serum albumin in PBS for 15min, and
subsequently incubated overnight with primary antibodies against
anti-D2-40 (Covance, Princeton, NJ) and LYVE-1 (AngioBio,
Del Mar, CA). Slides were washed three times with Tris-buffered
saline between the antibody incubations. Visualization was
performed with 3-amino-9-ethyl carbazole (Dako, Carpinteria, CA)
chromogenic substrate. Subsequently, the slides were counterstained
with hematoxylin. The positive area of LYVE-1 was evaluated from
the unit area (0.22mm2) and expressed as a percentage per unit area
using a digital image analysis program (AnalySIS, Soft Imaging
System).
Quantitative real-time RT-PCR
Total RNA was extracted from the kidney homogenates using Trizol
(Invitrogen). The Transcriptor First Strand cDNA Synthesis Kit
(Roche, Mannheim, Germany) was used to synthesize cDNA from
total RNA according to the manufacturer’s protocol. Quantitative
real-time RT-PCR of mouse Ang1, Ang2, VEGF-A, VEGF-B,
VEGF-C, and VEGF-D from kidney was performed in a 7900HT
Fast Real-Time PCR System (Applied Biosystems, Carlsbad, CA).
A 10-fold dilution of each cDNA was amplified in a 10 ml volume,
using the SYBR Green PCR Master Mix (Applied Biosystems), with
200 nmol/l final concentrations of each primer (Supplementary
Table S1 online). The PCR program was as follows: 10min at 95 1C,
then 95 1C for 10 s, and 60 1C for 30 s for 50 cycles. To confirm the
use of equal amounts of RNA in each reaction, all samples were
checked in parallel for glyceraldehyde 3-phosphate dehydrogenase
mRNA expression. Supplementary Table S1 summarizes the primer
sequences of mouse Ang1, Ang2, VEGF-A, VEGF-B, VEGF-C, and
VEGF-D, and glyceraldehyde 3-phosphate dehydrogenase.
Depletion of macrophages with clodronate treatment and
blockade of VEGF-C
Clodronate was purchased from Sigma and liposome-encapsulated
clodronate was prepared according to previously described
methods.42 For systemic depletion of macrophages, clodronate
liposome (50mg/kg) was administered through the peritoneum 1
day before operation and every second day before collecting the
kidney sample.4 Empty control liposome was injected as a control.
Immunoblotting
Immunoblotting was performed as previously described.21 Bone
marrow–derived macrophages, Raw 264.7 cells, MPT cells, and HK2
cells were homogenized, and immunoblot analysis of protein
expression was carried out using routine procedures. The primary
antibodies to VEGF-C and arginase-1 (Abcam, Cambridge, MA)
and iNOS (Santa Cruz) were used. The results of densitometric
analyses are reported as the relative ratio to actin. The relative ratio
measured in bone marrow–derived macrophages, Raw 264.7 cells,
MPT cells, and HK2 cells treated with control buffer is arbitrarily
presented as 1.
Capillary-like tube formation assay
In vitro tube formation assay was performed in a three-dimensional
culture of hLECs on ECM gel (Sigma-Aldrich).43
Migration assay
The migration assay with hLECs was performed using a modified
Boyden chamber (NeuroProbe, Cabin John, MD) as described
previously.43
Cell proliferation by XTT assay
Proliferation of hLECs was measured using a Cell Proliferation Kit II
(XTT; Roche) in accordance with the manufacturer’s protocol.
Enzyme-linked immunosorbent assay
VEGF-C and VEGF-D were measured using an enzyme-linked
immunosorbent assay kit in accordance with the manufacturer’s
protocol.
Statistical analysis
Data are means±s.d. Student’s t-test between two groups was
performed to compare the means of normally distributed
continuous variables. Comparison between three groups was
performed by one-way analysis of variance followed by
Dunnett’s comparison test. The association between variables has
been tested by Pearson’s correlation. Statistical significance was set
at Po0.05.
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